Skip to main content

69 publications

Name Date Type Actions

2009 activity report

21/04/2010 Annual Report

2009 annual earnings

March 31, 2010 – (Lure, France) – Vétoquinol’s Board of Directors, meeting on March 11, 2010, reviewed the Group’s business and approved its 2009 financial statements.

31/03/2010 Public releases

2009 Annual earnings

2009 Annual earnings

01/04/2010 Annual Report

2023 ANNUAL RESULTS

Annual sales: €529m (stable at constant exchange rates)
Essentials sales: €313m (+4.5% at constant exchange rates)
Net income - Group share: €56m (10.5% of sales)
EBITDA: €113m (21.3% of sales)
Free cash-flow: €89m

20/03/2024 Public releases

2024 Calendar of financial communication

Vetoquinol published its calendar of financial communication for 2024.

03/01/2024 Agenda

ANNUAL RESULTS 2023 (slideshow)

01.2023 Highlights
02.2023 Consolidated financial statements
03.Strategy and outlook

20/03/2024 Annual Report

Annual sales 2023: €529 million

Annual Sales of Essential products: €313 million (up 4.5% at constant exchange rates)

24/01/2024 Public releases

Assemblée Générale Ordinaire du 7 mai 2010 : texte des résolutions

PREMIERE RESOLUTION : Approbation des comptes sociaux de l’exercice 2009
<br>
DEUXIEME RESOLUTION :
Approbation des comptes consolidés de l’exercice 2009
<br>
TROISIEME RESOLUTION :
Affectation du résultat

30/03/2010 Shareholders´s Meeting

Availability of the 2023 universal registration document

On 24 April 2024, Vetoquinol filed its 2022 Universal Registration Document with the Autorité des Marchés Financiers (AMF) in ESEF (European Single Electronic Format).

24/04/2024 Public releases

BALO : Notice of meeting

Shareholders are invited to attend the Combined General Meeting to be held on Tuesday May 28, 2024 at 11 a.m. at the Company's registered office, Magny-Vernois 70 200 LURE, in order to deliberate on the following agenda and draft resolutions

22/04/2024 Shareholders´s Meeting